CytomX Therapeutics CTMX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$18.25M+31.2% | -$26.51M-86.3% | -$14.23M-9,140% | -$154K-101% | $23.53M+24.6% | ||
| $4.71M+218% | $1.48M+6.9% | $1.38M-3.3% | $1.43M-28.7% | $2.01M+6.6% | ||
| -$25.55M-9.9% | -$23.24M-49.5% | -$15.55M+1.3% | -$15.75M+25.1% | -$21.04M-5.7% | ||
| $0-100% | $201K— | —— | $27K-77.3% | $119K+48.8% | ||
| -$192.78M-1,237% | -$14.42M— | $0+100% | -$76.36M-350% | $30.6M+102% | ||
| $234.49M+1,309% | $16.64M+6,478% | $253K-99.7% | $93.55M— | $0-100% | ||
| $16.16M+177% | -$21.02M-41.5% | -$14.86M-1,134% | $1.44M-85.0% | $9.55M— | ||
| -$25.55M-9.0% | -$23.44M-52.0% | -$15.42M+2.3% | -$15.78M+25.4% | -$21.16M-5.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CytomX Therapeutics generate?
- CytomX Therapeutics (CTMX) generated -$80.1M in operating cash flow over the trailing twelve months.
- What is CytomX Therapeutics's free cash flow?
- After $347.0K of capital expenditures, CytomX Therapeutics's free cash flow was -$80.2M over the trailing twelve months, up 1.7% year over year.
- Where does CytomX Therapeutics's cash flow data come from?
- Every line is extracted from CytomX Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
